Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Dicerna Pharmaceutic
(NQ:
DRNA
)
24.64
USD
UNCHANGED
Streaming Delayed Price
Updated: 5:01 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Dicerna Pharmaceutic
< Previous
1
2
3
4
5
6
7
8
9
Next >
PBE's Holdings Imply 11% Gain Potential
December 30, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
First Week of DRNA February 2021 Options Trading
December 18, 2020
Investors in Dicerna Pharmaceuticals Inc (DRNA) saw new options become available this week, for the February 2021 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
Tags
Stocks
From
Market News Video
Stocks Generating Improved Relative Strength: Dicerna Pharmaceuticals
December 15, 2020
Dicerna Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
Notable Friday Option Activity: MAXR, DRNA, OPCH
December 11, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Maxar Technologies Inc (MAXR), where a total volume of 5,451 contracts has been...
Tags
Stocks
From
Market News Video
Dicerna Pharmaceuticals Trying To Close In On Key Technical Benchmark
November 30, 2020
Dicerna Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
From
Investor's Business Daily
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
November 15, 2020
Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market. The ...
Tags
DRNA
PRPO
General
From
Benzinga
Analysts Anticipate ESML Will Reach $33
November 13, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
November 05, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
CTMX
ARNA
TBPH
From
Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
November 01, 2020
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ...
Tags
CTLT
JAZZ
RTRX
From
Benzinga
IBD Rating Upgrades: Dicerna Pharmaceuticals Shows Improved Relative Price Strength
October 29, 2020
A Relative Strength Rating upgrade for Dicerna Pharmaceuticals shows improving technical performance. Will it continue?
From
Investor's Business Daily
Dicerna Pharmaceuticals (DRNA) Shares Cross Above 200 DMA
October 15, 2020
In trading on Thursday, shares of Dicerna Pharmaceuticals Inc (DRNA) crossed above their 200 day moving average of $20.51, changing hands as high as $20.74 per share. Dicerna Pharmaceuticals Inc shares...
Tags
Stocks
From
Market News Video
Vertex Tumbles As It Stops Testing On Protein Deficiency Treatment
October 15, 2020
Shares of Vertex plunged after hours Wednesday after the company announced it planned to stop testing on a drug designed to treat protein deficiencies. VRTX stock fell by double digits.
From
Investor's Business Daily
Noteworthy Thursday Option Activity: X, UNH, DRNA
October 15, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in United States Steel Corp. (X), where a total volume of 59,397 contracts has been...
Tags
Stocks
From
Market News Video
Implied PBE Analyst Target Price: $75
October 13, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Interesting DRNA Put And Call Options For November 20th
September 21, 2020
Investors in Dicerna Pharmaceuticals Inc (DRNA) saw new options become available this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
Tags
Stocks
From
Market News Video
Top Buys by Top Brass: CEO Fambrough's $180.6K Bet on DRNA
September 18, 2020
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider...
Tags
Stocks
From
Market News Video
Arrowhead Pharma Reveals Positive Data On Drug To Treat Liver Disease; ARWR Stock Jumps
September 16, 2020
Arrowhead Pharma posted positive clinical trials data on a promising drug to treat a rare genetic liver disease, and ARWR stock soared near a nine-moth high; shares of rival Dicerna also jumped.
From
Investor's Business Daily
Grab This Bargain Even Cheaper Than CEO Fambrough Did
September 08, 2020
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on September 1, Dicerna Pharmaceuticals Inc's CEO, Douglas...
Tags
Stocks
From
Market News Video
Friday 9/4 Insider Buying Report: RGT, DRNA
September 04, 2020
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their...
Tags
Stocks
From
Market News Video
Stocks With Rising Relative Strength: Dicerna Pharmaceuticals
August 10, 2020
A Relative Strength Rating upgrade for Dicerna Pharmaceuticals shows improving technical performance. Will it continue?
From
Investor's Business Daily
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
August 06, 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) ABIOMED, Inc. (NASDAQ: ABMD) Aerpio Pharmaceuticals Inc ...
Tags
IPOs
ACHV
SPRO
From
Benzinga
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
August 02, 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical ...
Tags
PEN
BCRX
PACB
From
Benzinga
2 Stocks to Hold for the Next 20 Years
July 21, 2020
Two decades is a long time, but these up-and-coming biopharma companies could earn significantly larger valuations in that span.
Tags
DRNA
FATE
JNJ
From
Motley Fool
Interesting DRNA Put And Call Options For September 18th
July 20, 2020
Investors in Dicerna Pharmaceuticals Inc (DRNA) saw new options begin trading this week, for the September 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the...
Tags
Stocks
From
Market News Video
Sum Up The Pieces: FYC Could Be Worth $46
July 08, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Dicerna Pharmaceuticals Shows Rising Price Performance With Jump To 91 RS Rating
June 26, 2020
Dicerna Pharmaceuticals sees its Relative Strength Rating hit the elite 90-plus level.
From
Investor's Business Daily
Dicerna Pharmaceuticals Moves Up In Market Cap Rank, Passing Under Armour
June 25, 2020
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Dicerna Pharmaceuticals Inc (DRNA) was identified as having a larger market cap than the smaller end of the...
Tags
Stocks
From
Market News Video
2 Top Small-Cap Stocks to Buy Right Now
June 12, 2020
Volatile stock market or not, these two drug developers are well positioned for long-term success.
Tags
CHRS
PFE
AMGN
From
Motley Fool
Is Arrowhead Pharmaceuticals a Buy?
May 24, 2020
The development-stage genetic medicine company is eager to convert its intriguing potential into tangible progress.
Tags
LLY
ALXN
JNJ
From
Motley Fool
Is Alnylam Pharmaceuticals a Buy?
May 21, 2020
The stock is up an amazing 2,100% since the company went public, stomping the S&P 500.
Tags
Market News
ALNY
NVS
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.